Serum BDNF levels in suicide attempters related to psychosocial stressors: A comparative study with depression

Neuropsychobiology

Volumn 56, Issue 2-3, 2008, Pages 93-97

  Deveci, Artuner ^a   Aydemir, Omer ^a   Taskin, Oryal ^a   Taneli, Fatma ^a   Esen Danaci, Aysen ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Brain derived neurotrophic factor; Major depressive disorder; Stress; Suicide

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFORMED CONSENT; KRUSKAL WALLIS TEST; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MENTAL STRESS; NEUROBIOLOGY; NONPARAMETRIC TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHIATRIC DIAGNOSIS; SUICIDE ATTEMPT; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; SUICIDE, ATTEMPTED;

EID: 40349086089     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111539     Document Type: Article

References (35)

1. Roy A: Psychiatric emergencies;in Sadock BJ, Sadock VA (eds): Kaplan and Sadock's Comprehensive Textbook of Psychiatry, ed 7. Baltimore, Williams & Wilkins, 2000, pp 2031-2055.
2. Gould MS, Wallenstein S, Kleinman M: Time-space clustering of teenage suicide. Am J Epidemiol 1990;131:71-78.
3. Baxter D, Appleby L: Case register study of suicide risk in mental disorders. Br J Psychiatry 1999;175:322-326.
4. Sir A: Diyarbakir'da Özkiyim ve Özkiyim Girişimleri. Turk Psikiyatri Derg 1999;10:50-58.
5. McClure GMG: Changes in suicide in England and Wales, 1960-1997. Br J Psychiatry 2000;176:64-67.
6. Jones JS, Stanley B, Mann JJ, Frances AJ, Guido JR, Traskman-Bendz L, Winchel R, Brown RP, Stanley M: CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 1990;147:1225-1227.
7. Nordstrom P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L: CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994;24:1-9.
8. Kamali M, Oquendo MA, Mann JJ: Understanding the neurobiology of suicidal behavior. Depression Anxiety 2001;14:164-176.
9. Mann JJ, Brent DA, Arango V: The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 2001;24:467-477.
10. Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819-828.
11. Marazziti D, Presta S, Silvestri S, Battistini A, Mosti L, Balestri S, Palego L, Conti L: Platelet markers in suicide attempters. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:375-383.
12. McAllister AK: Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci 2001;58:1054-1060.
13. Poo MM: Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001;2:24-32.
14. Spina MB, Hyman C, Squinto S, Lindsay RM: Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity. Ann NY Acad Sci 1992;648:348-350.
15. Lewin GR, Barde YA: Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317.
16. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768-1777.
17. Scaccianoce S, Lombardo K, Angelucci I: Nerve growth factor brain concentration and stress: changes depend on type of stress-or and age. Int Dev Neurosci 2000;18:469-479.
18. Alfonso J, Pollevick GD, Vander Hart MG, Flugge G, Fucks E, Frasch AC: Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 2004;19:659-666.
19. Lopez JF, Vazquez DM, Chalmers DT, Watson SJ: Regulaton of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann NY Acad Sci 1997;836:106-134.
20. Duman RS: Synaptic plasticity and mood disorders. Mol Psychiatry 2002;7(suppl 1):29-34.
21. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in depressed patients. Psychiatry Res 2002;109:143-148.
22. Altar CA: Neurotrophins and depression. Trends Pharmacol Sci 1999;20:59-61.
23. Chen B, Dowlatshaki D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001;50:260-265.
24. Scaccianoce S, Del Bianco P, Caricasole A, Nicoletti F, Catalani A: Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience 2003;121:825-828.
25. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003;54:70-75.
26. Aydemir O, Deveci A, Taneli F: The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:261-265.
27. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804-815.
28. Ozkurkcugil A, Aydemir O, Yildiz M, Esen Danaci A, Koroglu E: Adaptation into Turkish and reliability study of structured clinical interview for DSM-IV axis I disorders. Med Treat J 1999;12:233-236.
29. Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ: Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 1992;56:491-501.
30. Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, Chrousos GP, Bornstein SR: Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001;6:540-546.
31. Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB: Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005;57:336-342.
32. Brent DA, Mann JJ: Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005;133:13-24.
33. Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH: Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:78-85.
34. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R: Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotrophic drugs. Mol Brain Res 2005;136:29-37.
35. Hong CJ, Yu YW, Lin CH, Tsai SJ: An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 2003;349:206-208.